[en] INTRODUCTION: The Annual Congress of the European Association of Nuclear Medicine took place in Copenhagen on October 13-17, 2007. The event is the major scientific and professional effort in the field of nuclear medicine in Europe. The most important developments in the fields of instrumentation, radionuclide production, radiochemistry, radiotherapy, as well as the clinical imaging fields of neurology, cardiology, oncology, and general sciences were reported. OBJECTIVE: This paper emphasizes the major findings and trends at this important gathering. This review is, however, only a brief summary of the large amount of data discussed.
Disciplines :
Radiology, nuclear medicine & imaging
Author, co-author :
Knuuti, Juhani
Hustinx, Roland ; Centre Hospitalier Universitaire de Liège - CHU > Médecine nucléaire
Language :
English
Title :
Highlights of the annual congress of the European Association of Nuclear Medicine, Copenhagen 2007.
Publication date :
2008
Journal title :
European Journal of Nuclear Medicine and Molecular Imaging
ISSN :
1619-7070
eISSN :
1619-7089
Publisher :
Springer Science & Business Media B.V., New York, United States - New York
Perk, L.R., Stigter-Van Walsum, M., Visser, G.W.M., Kloet, R.W., Mjwd, V., Leemans, C.R., Quantitative PET imaging of Met-expressing human cancer xenografts with 89Zr-labeled monoclonal antibody DN30 (2007) Eur J Nucl Med Mol Imaging, 34, p. 252. , Suppl 2
Morgenstern, A., Abbas, K., Bruchertseifer, F., Lebeda, O., Simonelli, F., Stursa, J., Production of U-230/Th-226 for targeted alpha therapy (2007) Eur J Nucl Med Mol Imaging, 34, p. 260. , Suppl 2
Morgenstern, A., Abbas, K., Bruchertseifer, F., Martin, S., Qu, C., Simonelli, F., In vitro evaluation of the cytotoxicity of the novel alpha cascade emitter Th-226 in comparison with Bi-213 (2007) Eur J Nucl Med Mol Imaging, 34, p. 211. , Suppl 2
Komar, G., Seppänen, M., Eskola, O., Grönroos, T., Lindholm, P., Forsback, S., [18F]EF5: A new hypoxia-avid probe to image head and neck cancer (2007) Eur J Nucl Med Mol Imaging, 34, p. 132. , Suppl 2
Saba, W., Valette, H., Peyronneau, M., Bramoullé, Y., Coulon, C., Curet, O., [11C]SL-25.1188, a new radioligand to study the monoamine oxidase type B with PET: Preclinical characterisation (2007) Eur J Nucl Med Mol Imaging, 34, p. 137. , Suppl 2
Kao, C.K., Xie, H., Szajek, L.P., Liao, C., Hsu, C.W., Kao, P., [18F]FBAU 3′,5′-dibenzoate as a potential lipophilic prodrug for neurogenesis imaging (2007) Eur J Nucl Med Mol Imaging, 34, p. 138. , Suppl 2
Serdons, K., Koole, M., Dupont, P., Vermaelen, P., Vandenberghe, R., Vandenbulcke, M., Preclinical evaluation and human dosimetry of the new 18F-labelled amyloid imaging agent KS28 (2007) Eur J Nucl Med Mol Imaging, 34, p. 138. , Suppl 2
Sharma, S.K., Joshua, A.V., Strelkov, A., Scott, J.R., Abrams, D.N., Postema, E.J., Synthesis, structure activity relationship, radiolabeling and biodistribution studies on ERC-9 (2007) Eur J Nucl Med Mol Imaging, 34, p. 139. , Suppl 2
Marner, L., Gillings, N., Gunn, R.N., Comley, R., Baaré, W., Hasselbalch, S.G., Quantification of 11C-SB207145-PET for 5-HT4 receptors in the human brain: Preliminary results (2007) Eur J Nucl Med Mol Imaging, 34, p. 159. , Suppl 2
Varrone, A., Schou, M., Takano, A., Steiger, C., Finnema, S., Chalon, S., Preliminary evaluation of a new dopamine transporter radioligand for PET imaging: [18F]FE-PE2I (2007) Eur J Nucl Med Mol Imaging, 34, p. 205. , Suppl 2
Dong, M., Lin, X., Cai, H., Zha, J., Xue, F., Zhang, Z., Synthesis and quality control of new molecular imaging agent (18F-FZMS) for Alzheimer's disease (2007) Eur J Nucl Med Mol Imaging, 34, p. 286. , Suppl 2
Falzon, C.L., Ackermann, U., Tochon-Danguy, H., Scott, A., Spratt, N., Howells, D., Evaluation of novel PET imaging agents for the identification of the ischemic penumbra in stroke (2007) Eur J Nucl Med Mol Imaging, 34, p. 332. , Suppl 2
Haberkorn, U., Mier, W., Eisenhut, M., Beijer, B., Altmann, A., Radiolabeling and biodistribution of PKF115-584, an inhibitor of the Wnt signalling pathway (2007) Eur J Nucl Med Mol Imaging, 34, p. 395. , Suppl 2
Manchanda, R., Golding, R.G.M., Zhang, W., Benedum, T.E., Lim, C., Choi, S.R., Radiofluorinated alkynes as PET agents for the detection of amyloid plaques (2007) Eur J Nucl Med Mol Imaging, 34, p. 398. , Suppl 2
Von Guggenberg, E., Helbok, A., Sallegger, W., Andreae, F., Virgolini, I.J., Decristoforo, C., New class of radiolabelled minigastrins for targeting CCK2 positive tumours (2007) Eur J Nucl Med Mol Imaging, 34, p. 179. , Suppl 2
Garcia Garayoa, E., Schweinsberg, C., Maes, V., Blanc, A., Bläuenstein, P., Tourwé, D., Double targeting of prostate cancer xenografts with radiolabeled neurotensin and bombesin analogues (2007) Eur J Nucl Med Mol Imaging, 34, p. 181. , Suppl 2
Gourni, E., Bouziotis, P., Paravatou, M., Loudos, G., Sakellios, N., Psimadas, D., Comparative in vivo evaluation of two 99mTc-labeled bombesin derivatives (2007) Eur J Nucl Med Mol Imaging, 34, p. 180. , Suppl 2
Fragogeorgi, E.A., Zikos, C., Paravatou, M., Bouziotis, P., Mitsokapas, N., Xanthopoulos, S., In vitro and in vivo evaluation of new 99mTc-bombesin analogues for diagnostic applications (2007) Eur J Nucl Med Mol Imaging, 34, p. 189. , Suppl 2
Zlatopolskiy, B., Urusova, E., Neumaier, B., Vogg, A.T.J., Reske, S.N., Preparation and radiolabeling of DOTA-extended SOM230 analogues (2007) Eur J Nucl Med Mol Imaging, 34, p. 190. , Suppl 2
Aruva, M.R., Zhang, K., Shanthly, N., Cardi, C.A., Patel, C.A., Rattan, S., PET imaging of prostate cancer: A new approach to an old problem (2007) Eur J Nucl Med Mol Imaging, 34, p. 190. , Suppl 2
Pöyhönen, T.A., Huttunen, M., Autio, A., Virsu, P., Salomäki, S., Wilson, I., [68]Ga-DOTA-peptide targeting matrix metalloproteinase 9 in melanoma xenografts (2007) Eur J Nucl Med Mol Imaging, 34, p. 200. , Suppl 2
Behe, M., Baumeister, P., Laverman, P., Boerman, O.C., Oyen, W.J.G., Ramaswamy, A., Beta-cell imaging with radiolabelled GLP-1 analogs (2007) Eur J Nucl Med Mol Imaging, 34, p. 201. , Suppl 2
Hsia, C., Lin, C., Shen, L., Chen, H., Su, Y., Preparation and biological characterization of novel HL91-derivative analog for hypoxic tumor imaging (2007) Eur J Nucl Med Mol Imaging, 34, p. 202. , Suppl 2
Miot-Noirault, E., Redini, F., Vidal, A., Rapp, M., Gouin, F., Madelmont, J., 99mTc-NTP 15-5 imaging for the early and specific diagnosis of chondrosarcoma: Proof of concept in rats (2007) Eur J Nucl Med Mol Imaging, 34, p. 251. , Suppl 2
Martini, D., Valentini, G., Panichelli, P., Malizia, C., Colonna, M., Castignani, L., Synthesis, characterization and preliminary biological evaluation of [64Cu]ethhylenedicysteine-nitroimidazole and comparative studies with [18F]fluoromisonidazole (2007) Eur J Nucl Med Mol Imaging, 34, p. 331. , Suppl 2
Autio, A.K., Pöyhönen, T.A., Virsu, P., Salomäki, A., Jalkanen, S., Roivainen, A., Tumour versus inflammation imaging (2007) Eur J Nucl Med Mol Imaging, 34, p. 397. , Suppl 2
Blower, P.J., Surfraz, M., King, R., Biagini, S., Mather, S.J., How do HYNIC-conjugated peptides bind technetium? Insights from LC-MS and stability studies (2007) Eur J Nucl Med Mol Imaging, 34, p. 148. , Suppl 2
Surfraz, M., King, R., Mather, S., Biagini, S., Blower, P., Technetium-binding in labelled HYNIC-peptide conjugates: Role of coordinating amino acids (2007) Eur J Nucl Med Mol Imaging, 34, p. 148. , Suppl 2
Ahlgren, S., Orlova, A., Tran, T., Abrahmsén, L., Feldwisch, J., Tolmachev, V., Targeting of HER2-expressing tumours using directly 99mTc-labelled recombinant Affibody molecule ZHER2:342 with C-terminal engineered cysteine (2007) Eur J Nucl Med Mol Imaging, 34, p. 190. , Suppl 2
Vandenberghe, S., Lemahieu, I., Impact of time-Of-flight on reconstruction performance and image quality (2007) Eur J Nucl Med Mol Imaging, 34, p. 238. , Suppl 2
Lamare, F., Bettinardi, V., Visvikis, D., A simplified local respiratory motion correction (LRMC) for PET/CT imaging (2007) Eur J Nucl Med Mol Imaging, 34, p. 145. , Suppl 2
Pena, H., Cantinho, G.G., Shwartz, S.C., Figueiredo, S., Marona, D., Monteiro, J., Wide beam reconstruction technology-does it respect myocardial perfusion SPECT functional parameters? (2007) Eur J Nucl Med Mol Imaging, 34, p. 124. , Suppl 2
Serdons, K., Koole, M., Dupont, P., Vermaelen, P., Vandenberghe, R., Vandenbulcke, M., Preclinical evaluation and human dosimetry of the new 18F-labelled amyloid imaging agent KS28 (2007) Eur J Nucl Med Mol Imaging, 34, p. 138. , Suppl 2
Nikolaus, S., Beu, M., Antke, C., Kley, K., Wirrwar, A., Müller, H., In vivo quantitation of endogenous DA release in the rat striatum using small animal tomography (2007) Eur J Nucl Med Mol Imaging, 34, p. 159. , Suppl 2
Camacho, V., Estorch, M., Paredes, P., Flotats, A., Rodriguez-Revuelto, A., Rivera, E., Usefulness of cardiac MIBG scintigraphy to differentiate Lewy Bodies Dementia from other neurodegenerative disease with cognitive impairment (2007) Eur J Nucl Med Mol Imaging, 34, p. 153. , Suppl 2
Umeda, I.O., Sema, H., Suzuki, S., Kurihara, J., Kosano, H., Kaminaga, T., 99mTc-sestamibi washout induced by the reversible hypoxic damage in electrically paced, isolated rat hearts (2007) Eur J Nucl Med Mol Imaging, 34, p. 276. , Suppl 2
Fonge, H., Vunckx, K., Lixin, J., Wang, H., Prinsen, K., Lemmens, C., Non invasive in vivo μsPECT imaging of apoptosis and necrosis in rabbits with a novel site specific 99mTc-labelled annexin-A5-HYNIC derivative and mono-[123I]iodohypericin after acute reperfused myocardial infarction (2007) Eur J Nucl Med Mol Imaging, 34, p. 149. , Suppl 2
Prior, J.O., Modolo, L., Kosinski, M., Allenbach, G., Malterre, J., Valenta, I., Myocardial blood flow quantitation using Rubidium-82 cardiac PET: Direct comparison with oxygen-15 water in volunteers and patients (2007) Eur J Nucl Med Mol Imaging, 34, p. 170. , Suppl 2
Kajander, S., Ukkonen, H., Knuuti, J., Low dose sequential and conventional spiral cardiac CT angiography with a Hybrid CT-PET-scanner: Image quality and dose comparison (2007) Eur J Nucl Med Mol Imaging, 34, p. 150. , Suppl 2
Rehak, Z., Fojtik, Z., Opl, P., Hofirek, I., Bolcak, K., Niznanska, V., The role of 18F-FDG PET in the diagnosis of large vessel vasculitis (2007) Eur J Nucl Med Mol Imaging, 34, p. 285. , Suppl 2
Hubalewska-Dydejczyk, A., Stompór, T., Kalembkiewicz, M., Mikolajczak, R., Sowa-Staszczak, A., Krzanowski, M., The association between carotid artery plaque scintigraphy using 131I-labelled IL-2 and serum levels of inflammatory markers in end-stage renal disease (ESRD) patients treated with peritoneal dialysis (PD) (2007) Eur J Nucl Med Mol Imaging, 34, p. 233. , Suppl 2
Laitinen, I., Marjamäki, P., Haaparanta, M., Någren, K., Laine, V.J.O., Leppänen, P., Uptake of 11C-PK11195, a marker of inflammatory cells, into atherosclerotic plaques in mice (2007) Eur J Nucl Med Mol Imaging, 34, p. 233. , Suppl 2
Chua, S., Groves, A., Kayani, I., Menezes, L., Gacinovic, S., Du, J., The impact of 18F-FDG PET/CT in patients with liver metastases (2007) Eur J Nucl Med Mol Imaging, 34, p. 184. , Suppl 2
Bipat, S., Van Leeuwen, M.S., Comans, E.F., Pijl, M.E., Bossuyt, P.M., Zwinderman, A.H., Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis (2005) Radiology, 237, pp. 123-131. , 1
Kinkel, K., Lu, Y., Both, M., Warren, R.S., Thoeni, R.F., Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): A meta-analysis (2002) Radiology, 224, pp. 748-756. , 3
Kong, G., Jackson, C., Koh, D., Sharma, B., Lewington, V., Cook, G., The value of 18-FDG PET/CT in the management of colorectal liver metastases-comparison with CT and Liver MRI (2007) Eur J Nucl Med Mol Imaging, 34, p. 184. , Suppl 2
Strobel, K., Schäfer, M., Veit-Haibach, P., Pestalozzi, B., Seifert, B., Clavien, P., Contrast enhanced FDG-PET/CT-"one stop shop" imaging for pancreatic cancer resectability assessment (2007) Eur J Nucl Med Mol Imaging, 34, p. 162. , Suppl 2
Izarduy, L., Mucientes, J., Lapeña, L., Martínez, M., Rodríguez, B., Carmona, E., Diagnostic efficacy of PET and PET/CT in evaluation of treatment response in Hodgkin disease and non-Hodgkin lymphomas: A systematic review (2007) Eur J Nucl Med Mol Imaging, 34, p. 298. , Suppl 2
Cheson, B.D., Pfistner, B., Juweid, M.E., Gascoyne, R.D., Specht, L., Horning, S.J., The International Harmonization Project on Lymphoma. Revised response criteria for malignant lymphoma (2007) J Clin Oncol, 25, pp. 579-586. , 5
De Geus-Oei, L., Van Der Heijden, H.F.M., Visser, E.P., Hermsen, R., Van Hoorn, B.A., Timmer-Bonte, J.N., Chemotherapy response evaluation with FDG-PET in patients with non-small-cell lung cancer (2007) Eur J Nucl Med Mol Imaging, 34, p. 143. , Suppl 2
Castellucci, P., Sansovini, M., Farsad, M., Montini, G., Nanni, C., Di Fabio, F., 18F-FDG PET/CT before and after radio-chemotherapy in patients with lower rectal cancer (2007) Eur J Nucl Med Mol Imaging, 34, p. 299. , Suppl 2
Cascini, G.L., Avallone, A., Delrio, P., Guida, C., Tatangelo, F., Marone, P., 18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer (2006) J Nucl Med, 47, pp. 1241-1248. , 8
Huchet, V., Gutman, F., Kerrou, K., Cussenot, O., Haab, F., Doublet, J., Evaluation of PSA velocity as a selection criterion for FCH PET/CT in patients with biological recurrence of prostate cancer (2007) Eur J Nucl Med Mol Imaging, 34, p. 123. , Suppl 2
Antunes, P., Ginj, M., Zhang, H., Waser, B., Baum, R.P., Reubi, J.C., Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals? (2007) Eur J Nucl Med Mol Imaging, 34, pp. 982-993. , 7
Maecke, H.R., Hofmann, M., Haberkorn, U., (68)Ga-labeled peptides in tumor imaging (2005) J Nucl Med, 46, pp. 172S-178S. , Suppl 1
Baum, R.P., Prasad, V., Fanti, S., Detection of unknown primary neuroendocrine tumors (CUP-NET) using somatostatin receptor PET/CT: Results from two European Centers (2007) Eur J Nucl Med Mol Imaging, 34, p. 174. , Suppl 2
Prasad, V., Secknus, M.A., Lauer, B., Baum, R.P., Incidence and detection of cardiac metastases in patients with neuroendocrine tumors (NET): Role of Ga-68 DOTA-NOC receptor PET/CT (2007) Eur J Nucl Med Mol Imaging, 34, p. 193. , Suppl 2
Valdes Olmos, R.A., Van Der Poel, H.G., Sivro, F., Horenblas, S., Hoefnagel, C.A., SPECT-CT for anatomical sentinel node localization in prostate cancer (2007) Eur J Nucl Med Mol Imaging, 34, p. 311. , Suppl 2
Spanu, A., Chessa, F., Meloni, G.B., Sanna, D., Cottu, P., Manca, A., The role of high resolution planar scintimammography with dedicated breast camera (DBC) in the diagnosis of primary breast cancer (BC) (2007) Eur J Nucl Med Mol Imaging, 34, p. 306. , Suppl 2
Spanu, A., Chessa, F., Meloni, G.B., Sanna, D., Cottu, P., Manca, A., The usefulness of high resolution planar scintimammography with dedicated breast camera in the diagnosis of multifocal/multicentric primary breast cancer (BC) (2007) Eur J Nucl Med Mol Imaging, 34, p. 306. , Suppl 2
Dimou, E., Peck-Radosavljevic, M., Marosi, C., Roessler, K., Dietrich, W., Nasel, C., Value of tumor imaging using (123)I-vascular endothelial growth factor-165 (123I-VEGF165) (2007) Eur J Nucl Med Mol Imaging, 34, p. 215. , Suppl 2
Cornelissen, B., Oltenfreiter, R., Kersemans, V., Staelens, L., Frankenne, F., Foidart, J.M., In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker (2005) Nucl Med Biol, 32, pp. 431-436. , 5
Gmeiner Stopar, T., Fettich, J., Mlinaric-Rascan, I., Hojker, S., Slodnjak, I., Socan, A., 99mTc labeled Rituximab: A new non-Hodgkin's lymphoma imaging agent-first experience (2007) Eur J Nucl Med Mol Imaging, 34, p. 307. , Suppl 2
Baum, R.P., Wehrmann, C., Zachert, C., Mundschenk, J., Prasad, V., Wortmann, R., 5-year follow-up of peptide receptor radionuclide therapy (PRRT) in 379 patients with progressive somatostatin receptor positive neuroendocrine tumours (2007) Eur J Nucl Med Mol Imaging, 34, p. 220. , Suppl 2
Iten, F., Müller, B., MäcKe, H.R., Müller-Brand, J., Walter, M.A., Survival after (90Y-DOTA)-TOC therapy in metastasized de-differentiated thyroid cancer: Long-term results of a phase IIA clinical trial (2007) Eur J Nucl Med Mol Imaging, 34, p. 207. , Suppl 2
Iten, F., Müller, B., Schindler, C., Rochlitz, C., Oertli, D., MäcKe, H.R., Response to (90Y-DOTA)-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: A phase IIA clinical trial (2007) Eur J Nucl Med Mol Imaging, 34, p. 207. , Suppl 2
Wild, D., Frischknecht, M., Good, S., Zhang, H., Morgenstern, A., Bruchertseifer, F., Targeted radiotherapy of gastrin-releasing-peptide (GRP) receptor expressing prostate cancer: Therapeutic efficacy of 213Bi vs. 177Lu labelled DOTA-PEG4-Bombesin (7-14)(DOTA-PESIN) (2007) Eur J Nucl Med Mol Imaging, 34, p. 240. , Suppl 2
Brouwers, A.H., Mulders, P.F., De Mulder, P.H., Van Den Broek, W.J., Buijs, W.C., Mala, C., Lack of efficacy of two consecutive treatments of radioimmunotherapy with 131I-cG250 in patients with metastasized clear cell renal cell carcinoma (2005) J Clin Oncol, 23, pp. 6540-6548. , 27
Stillebroer, A.B., Hendrickx, B.W., Oosterwijk, E., De Weijer, K., Steffens, M.G., Boerman, O.C., Radioimmunotherapy of advanced renal cell carcinoma in patients with Lutetium-177 labeled monoclonal antibody cG250 (2007) Eur J Nucl Med Mol Imaging, 34, p. 169. , Suppl 2
Poepperl, G., Goetz, C., Rachinger, F., Gildehaus, F.G., Schnell, O., Tonn, J.C., Intracavavitary radioimmunotherapy in malignant gliomas using 1-131 and Re-188-labelled monoclonal anti-tenascin antibodies (2007) Eur J Nucl Med Mol Imaging, 34, p. 136. , Suppl 2
Wehrmann, C., Senfleben, S., Baum, R.P., Dosimetry in peptide receptor radionuclide therapy (PRRT) using Lu-177 DOTA-TATE: Intra- and inter-patient variability (2007) Eur J Nucl Med Mol Imaging, 34, p. 178. , Suppl 2
Ferrari, M., Cremonesi, M., Bartolomei, M., Orsi, F., De Cicco, C., Bonomo, G., Selective internal radiation therapy (SIRT) with 90Y-microspheres: Dosimetric and radiobiological considerations for multi-cycle treatments (2007) Eur J Nucl Med Mol Imaging, 34, p. 178. , Suppl 2
Iagaru, A., Zhu, H., Mari, C., Knox, S.J., Ganjoo, K., Goris, M.L., Comparison of 131I-Tositumomab (Bexxar®) and 90Y-Ibritumomab (Zevalin®) therapy of refractory/relapsed non-Hodgkin lymphoma (2007) Eur J Nucl Med Mol Imaging, 34, p. 168. , Suppl 2
Freudenberg, L.S., Jentzen, W., Müller, S.P., Bockisch, A., Disseminated iodine-avid lung metastases in differentiated thyroid cancer: A challenge to 124I-PET (2007) Eur J Nucl Med Mol Imaging, 34, p. 198. , Suppl 2
Mihailovic, J., Stefanovic, L., Malesevic, M., Radioiodine (131I) uptake in distant metastases as a predicting factor of survival in differentiated thyroid carcinoma patients (2007) Eur J Nucl Med Mol Imaging, 34, p. 231. , Suppl 2
Rajic, M.P., Ilic, S.S., Vlajkovic, M.Z., Avramovic, M.Z., Stevic, M., Sekulic, V., Comparison of two methods for glomerular filtration rate measurements: Modification of diet in renal disease formula and 99mTc-DTPA clearance (2007) Eur J Nucl Med Mol Imaging, 34, p. 228. , Suppl 2
Bashir, H., Anderson, P.J., Biassoni, L., Ridout, D., Gordon, I., Indirect radionuclide cystography in children-a review of practice and experience (2007) Eur J Nucl Med Mol Imaging, 34, p. 250. , Suppl 2
Nichols, K.J., Tomas, M.B., Tronco, G.G., Palestro, C.J., Factors affecting sensitivity for detection of parathyroid lesions (2007) Eur J Nucl Med Mol Imaging, 34, p. 197. , Suppl 2
Basu, S., Dadparvar, S., Housenic, M., Chryssikos, T., Bural, G., Alzeair, S., The value of FDG-PET for the evaluation of painful hip and knee arthroplasties: Comparison with 111In-labeled leukocyte/99mTc-sulfur colloid marrow imaging (2007) Eur J Nucl Med Mol Imaging, 34, p. 155. , Suppl 2
